Regencell Bioscience (RGC) stock jumps nearly 10% in choppy Nasdaq trade
Regencell Bioscience Holdings shares rose about 9.8% to $27.43 by early afternoon Monday, with trading volume reaching roughly 241,000 shares. No new disclosures or statements from the company accompanied the move. Traders are focused on the April 20 lock-up expiry, previously detailed in SEC filings.